ArticleAllergy2018
Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis.
Open access · greenAbstract readLetter
In one paragraph
Article in Allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- A Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated With Baseline Clinical Features and Successful Treatment Response.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023Trial
- Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2020Trial
- Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2019Trial
- Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis.The Journal of allergy and clinical immunology · 2026Article
- Roles of systemic CD4Research square · 2026Article
- Editorial: Atopic march and atopic multimorbidity.Frontiers in allergy · 2026Article
- Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease.Nature reviews. Immunology · 2024Review
- Mast Cell Esophagitis: A Novel Entity in Patients with Unexplained Esophageal Symptoms.Dysphagia · 2024Article
- Role of Mast Cells in Eosinophilic Gastrointestinal Diseases.Immunology and allergy clinics of North America · 2024Review
- Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.The Journal of allergy and clinical immunology · 2024Article
- Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults.Digestive diseases and sciences · 2024Article
- Eosinophilic Esophagitis: What's in a Name?Digestive diseases and sciences · 2024Article
- Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms.Cells · 2023Review
- Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2023Article
- Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis.Journal of clinical medicine · 2022Article
- Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021Article
- A Model Using Clinical and Endoscopic Characteristics Identifies Patients at Risk for Eosinophilic Esophagitis According to Updated Diagnostic Guidelines.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021Article
- Mast Cell Activation in the Systemic Sclerosis Esophagus.Journal of scleroderma and related disorders · 2021Article
- Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.The American journal of gastroenterology · 2020Article
- Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.JCI insight · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Manaswita TappataDivision of Gastroenterology and Hepatology, Department of Medicine, Chapel Hill, North Carolina.
Swathi EluriDivision of Gastroenterology and Hepatology, Department of Medicine, Chapel Hill, North Carolina.
Irina PerjarDepartment of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
Johnathan HollyfieldDepartment of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
Renee BetancourtDepartment of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
Cara RandallDepartment of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
John T WoosleyDepartment of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
Joshua B WechslerDivision of Pediatric Gastroenterology and Hepatology, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois.
Evan S DellonDivision of Gastroenterology and Hepatology, Department of Medicine, Chapel Hill, North Carolina.ORCID 0000-0003-1167-1101
University of North Carolina Health Care · USUniversity of North Carolina at Chapel Hill · USLurie Children's Hospital · US
Funding
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5MUNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3MPILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5MSHORT-TERM RESEARCH TRAININGT35DK007386 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Evan Samuel Dellon · 1986 to 2026
$4.1MRegulation of Ulcerative Colitis by mast cells and histamineK08DK097721 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WECHSLER, JOSHUA BRIAN · 2015 to 2019
$792kRisk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic EsophagitisK23DK090073 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DELLON, EVAN SAMUEL · 2011 to 2013
$541kNCBT 2015-IDG-1007NCI NIH HHS P30 CA016086NIDDK NIH HHS K08 DK097721NIDDK NIH HHS K23 DK090073NIDDK NIH HHS P30 DK034987NIDDK NIH HHS T35 DK007386NIEHS NIH HHS P30 ES010126
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultCell CountCohort StudiesEndoscopyEosinophilic EsophagitisEosinophilsFemaleHistologyHumansMaleMast CellsMiddle AgedYoung Adult
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.